v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (2,909,628) $ (28,048,400) $ (16,635,440)
Adjustments to reconcile net loss to net cash flows from operating activities:      
Depreciation and amortization 141,378 465,246 539,633
Stock-based compensation expense   2,293,754 477,864
(Gain) loss on disposal of property and equipment   (420) 1,438
Change in inventory reserves 31,451 301,017 347,893
Amortization of right-of-use assets   179,107 143,513
Foreign currency exchange gain (306,120) (25,096) (1,254,790)
Change in fair value of convertible notes (related party) (4,079,700) 4,093,000 2,376,900
Change in fair value of warrant liabilities (334,293) 93,832 119,628
Changes in assets and liabilities      
Accounts receivable   (87,632) 186,179
Inventories   (1,505,000) (156,743)
Prepaid expenses and other assets   (439,140) (156,379)
Accounts payable and other liabilities   282,567 155,984
Accrued expenses   92,633 119,562
Lease liabilities   (239,771) (197,384)
Contract liabilities   15,432 (22,436)
Net cash used in operating activities   (21,365,275) (13,938,599)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of property and equipment   (753,097) (299,854)
Proceeds from sale of property and equipment   420 0
Investment in convertible note (352,000) (352,000) 0
Purchases of marketable securities   (9,894,052) (7,405,750)
Proceeds from maturity of marketable securities   31,171,661 0
Net cash provided by (used in) investing activities   20,172,932 (7,705,604)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from issuance of common stock and restricted stock   43,422,613 44,139,201
Issuance costs of common stock and restricted stock   (1,838,508) (1,313,030)
Proceeds from exercise of options, net of expenses   2,120,830 373,182
Proceeds from warrants, net of expenses   46,214 0
Payments on financing obligation   0 (209,137)
Net cash provided by financing activities   43,751,149 42,990,216
Net change in cash and cash equivalents   42,558,806 21,346,013
Cash and cash equivalents - beginning of period   19,502,348 15,707,739
Effect of foreign currency exchange rate changes on cash and cash equivalents   39,135 1,284,973
Cash and cash equivalents - end of period 62,100,289 62,100,289 38,338,725
Supplemental cash flow disclosure      
Cash paid for interest   0 4,170
Noncash investing and financing activities      
Transfer from inventory to property and equipment   69,565 0
Property and equipment included in accounts payable or accrued expenses   47,653 9,756
Operating lease right-of-use assets in exchange for operating lease liability   43,303 30,128
Fair value adjustment for liability-classified options and warrants exercised   4,265,070 293,143
Options Held [Member]      
Adjustments to reconcile net loss to net cash flows from operating activities:      
Change in fair value of option liabilities (21,666) 1,107,353 15,979
Derivative [Member]      
Adjustments to reconcile net loss to net cash flows from operating activities:      
Change in fair value of option liabilities $ 0 $ 56,243 $ 0